Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Diltiazem hydrochloride
Drug ID BADD_D00675
Description Diltiazem is a benzothiazepine derivative with antihypertensive and vasodilating properties. Approved in 1982 by the FDA, it is a member of the non-dihydropyridine calcium channel blockers drug class. It works through various mechanisms of action, but it primarily works by inhibiting the calcium influx into cardiac and vascular smooth muscle during depolarization.[L10556] Compared to dihydropyridine drugs, such as [nifedipine], that preferentially act on vascular smooth muscle and [verapamil] that directly acts on the heart muscle, diltiazem displays an intermediate specificity to target both the cardiac and vascular smooth muscle.[T28] Being a potent vasodilator, diltiazem is used clinically as an antihypertensive, anti-arrhythmic, and as an anti-anginal agent [L6289] for the management of cardiovascular conditions such as hypertension, chronic stable angina, atrial fibrillation, atrial flutter. Apart from its main FDA-approved indications, diltiazem has also been used for numerous off-label indications, such as anal fissures (in topical formulations), migraine prophylaxis, pulmonary hypertension, and rest-related cramps in the lower extremities.[L6289] Typically available in extended-release oral and intravenous formulations, diltiazem is marketed under various brand names with Cardizem and Tiazac being the most common ones.
Indications and Usage For the treatment of Hypertension
Marketing Status Prescription; Discontinued
ATC Code C05AE03; C08DB01
DrugBank ID DB00343
KEGG ID D00616
MeSH ID D004110
PubChem ID 62920
TTD Drug ID D0OB1J
NDC Product Code 42291-187; 68788-7634; 42291-185; 47335-676; 47335-671; 62037-599; 53360-1211; 50090-0451; 68682-371; 71335-1585; 24979-028; 51079-926; 70934-565; 51079-924; 71335-0839; 70771-1035; 15894-0022; 55154-8197; 68682-994; 70771-1037; 71335-0579; 60687-206; 38779-0227; 68981-018; 63304-719; 63187-769; 0187-2045; 0378-6060; 50090-3062; 62991-1046; 0187-2049; 62037-600; 70518-3299; 17478-837; 68071-3264; 52544-693; 50742-251; 70518-3337; 0093-0319; 53360-1214; 50742-252; 68382-746; 71335-1611; 71335-1389; 62037-598; 53360-1213; 47335-670; 17478-937; 68682-006; 62037-698; 63304-721; 72189-344; 0187-0771; 0378-6090; 53360-1212; 65085-0002; 63629-7981; 68682-372; 63304-722; 0187-0772; 0378-6120; 68382-595; 53360-1210; 68682-008; 60505-0015; 70934-564; 0187-0795; 0615-8127; 70771-1033; 70518-0040; 16714-523; 68071-4371; 60687-562; 79572-015; 51754-3000; 47335-675; 42799-131; 50742-248; 68682-007; 71335-1043; 68382-748; 47335-672; 68682-009; 71335-1776; 63629-2154; 55154-8126; 47335-679; 49452-4881; 42799-132; 68462-562; 55154-8140; 70518-1017; 63629-7330; 50742-249; 70771-1031; 71335-1223; 68382-750; 0093-0320; 60687-573; 24979-027; 50090-3124; 58118-1007; 24979-030; 0187-2614; 68682-997; 0187-0796; 0615-8032; 0615-8129; 71335-0634; 50742-250; 68788-7237; 68382-749; 50090-2593; 51079-925; 0187-0792; 0615-8128; 47335-669; 70518-2506; 50090-5466; 0187-0797; 0187-2617; 68462-850; 10370-829; 63629-2153; 70934-854; 0409-4350; 47335-673; 16729-303; 70518-2683; 68382-596; 50090-2870; 63629-7896; 10370-831; 63629-2156; 68682-367; 63629-3649; 70771-1039; 51407-475; 70518-0820; 0187-0799; 52544-694; 68071-3214; 70934-210; 60505-0016; 47335-677; 0187-2050; 16714-524; 68071-3076; 53002-1521; 68682-521; 0615-8381; 24979-029; 62037-700; 0409-1171; 16714-525; 62331-005; 42291-186; 16729-305; 71335-0745; 63304-718; 63629-2159; 70518-1993; 10370-830; 47335-678; 60687-195; 68682-368; 68682-998; 68382-745; 70771-1032; 68462-851; 0641-9219; 0187-2046; 71335-0867; 70860-301; 68071-4005; 70518-2789; 0641-6013; 0615-8379; 0093-0318; 50090-5416; 24979-026; 51407-473; 63629-2158; 63629-2160; 52544-691; 68382-597; 68788-7870; 70934-559; 51754-3500; 71335-1001; 0093-0321; 0187-2048; 0615-8380; 0641-9217; 51407-474; 60687-228; 0187-2612; 71872-7062; 70771-1030; 70771-1036; 70771-1034; 62037-696; 71335-0879; 16729-304; 0395-8110; 68382-747; 42291-184; 0615-8033; 63629-7232; 60505-0014; 68682-369; 42799-129; 68682-993; 42799-130; 12780-2960; 62037-697; 63739-014; 63304-720; 50090-2884; 0228-2918; 63629-2155; 0641-9218; 12828-0037; 71872-7063; 0187-2616; 70771-1040; 60687-217; 68382-599; 68682-370; 52133-0013; 71335-0643; 63629-2157; 62037-597; 0187-2615; 63739-015; 68071-4664; 52544-695; 63629-8232; 71335-2029; 70934-563; 0641-6015; 0187-2047; 55154-8144; 0187-2613; 68071-4591; 70771-1038; 0641-6014; 70518-0109; 71335-0266; 62037-699; 10370-832; 77777-110; 0187-0798; 50090-5452; 68382-598; 63739-016; 71335-1897; 51407-476; 52544-692; 70518-1096; 68071-4242
Synonyms Diltiazem | Cardil | Cardizem | CRD-401 | CRD 401 | CRD401 | Tiazac | Dilacor XR | Dilren | Diltiazem Hydrochloride | Diltiazem Malate | Dilzem | Aldizem | Dilacor
Chemical Information
Molecular Formula C22H27ClN2O4S
CAS Registry Number 33286-22-5
SMILES CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Poisoning and toxicityCytochrome P450 2D6P10635T57392Not Available
Sudden cardiac deathPotassium voltage-gated channel subfamily KQT member 1P51787T49526Not Available
Sudden cardiac deathSodium channel protein type 5 subunit alphaQ14524T39716Not Available
Sudden cardiac deathPotassium voltage-gated channel subfamily E member 1P15382Not AvailableNot Available
Sudden cardiac deathPotassium voltage-gated channel subfamily H member 2Q12809T20251Not Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abnormal dreams19.02.03.001; 17.15.02.001--Not Available
Alopecia23.02.02.001--
Amblyopia06.02.01.001--Not Available
Amnesia19.20.01.001; 17.03.02.001--
Angina pectoris24.04.04.002; 02.02.02.002--
Angioedema23.04.01.001; 10.01.05.009--Not Available
Arterial injury12.01.11.008; 24.11.02.002--
Arthralgia15.01.02.001--
Atrioventricular block02.03.01.002--Not Available
Atrioventricular block first degree02.03.01.004--
Bleeding time prolonged13.01.02.002--Not Available
Blood creatine phosphokinase increased13.04.01.001--
Bradycardia02.03.02.002--Not Available
Bundle branch block02.03.01.009--Not Available
Cardiac failure02.05.01.001--
Constipation07.02.02.001--
Cough22.02.03.001--
Depression19.15.01.001--
Diarrhoea07.02.01.001--
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Dry mouth07.06.01.002--
Dysgeusia17.02.07.003; 07.14.03.001--
Dyspepsia07.01.02.001--
Dyspnoea22.02.01.004; 02.01.03.002--
Epistaxis24.07.01.005; 22.04.03.001--
Erythema multiforme10.01.03.015; 23.03.01.003--
Extrapyramidal disorder17.01.02.007--
Eye irritation06.04.05.003--Not Available
Face oedema23.04.01.004; 10.01.05.002; 08.01.07.003--
Fatigue08.01.01.002--
The 1th Page    1 2 3    Next   Last    Total 3 Pages